Programme stage |
Supporting evidence |
Study author(s) |
Stage 1: improved patient mobility |
Improved mobility outcomes |
Arnold et al. 2012 [54]; Campo et al. 2013 [55] |
Stage 2: improved vital bodily functions |
Improved physical functioning, improved urinary continence, improved daytime alertness |
Nelson et al. 2008 [4] |
Stage 3: reduced risk of healthcare associated/immobility-acquired complications |
Improved urinary continence; improved mobilisation |
Nelson et al. 2008 [4]; Arnold et al. 2012 [54]; Campo et al. 2013 [55] |
Stage 4: improved rate of recovery, greater quality of life and reduced length of stay |
Improved quality of patient care, and quality of life |
Nelson et al. 2008 [4] |
Stage 5: reduced need for assistance |
Improved physical functioning, improved urinary continence, improved engagement in activities, lower fall risk, and improved daytime alertness |
Nelson et al. 2008 [4] |
Stage 6: reduced strain related injury and better staff productivity |
Reduction in incidence rate for back MSDs, number of lost workdays, reduction in perceived shoulder and lower back strain |
Garg et al. 1992 [13]; Brophy et al. 2001 [15]; Owen et al. 2002 [6]; Collins et al. 2004 [16]; Fujishiro et al. 2005 [17]; Nelson et al. 2006 [12]; Garg 2012 [18] |
Stage 7: improved retention through less sick leave and turnover |
Greater reduction in lost workdays, reduced number of injury claims |
Brophy et al. 2001 [15]; Collins et al. 2004 [16]; Fujishiro et al. 2005 [17]; Nelson et al. 2006 [12]; Garg et al. 2012 [18]; Charney et al. 2006 [51] |
Stage 8: improved quality of care and financial outcomes |
Savings in compensation costs for back MSDs, and in days lost due to injury, reduced number of injury claims, improved quality of patient care, improved patient urinary continence |
Nelson et al. 2008 [4]; Brophy et al. 2001 [15]; Garg et al. 2012 [18]; Chhokar et al. 2005 [44]; Miller et al. 2006 [45]; Charney et al. 2006 [51] |